193 related articles for article (PubMed ID: 36733497)
1. The signaling function of IDO1 incites the malignant progression of mouse B16 melanoma.
Orecchini E; Belladonna ML; Pallotta MT; Volpi C; Zizi L; Panfili E; Gargaro M; Fallarino F; Rossini S; Suvieri C; Macchiarulo A; Bicciato S; Mondanelli G; Orabona C
Oncoimmunology; 2023; 12(1):2170095. PubMed ID: 36733497
[TBL] [Abstract][Full Text] [Related]
2. Targeting Indoleamine 2,3-Dioxygenase in Cancer Models Using the Novel Small Molecule Inhibitor NTRC 3883-0.
Grobben Y; de Man J; van Doornmalen AM; Muller M; Willemsen-Seegers N; Vu-Pham D; Mulder WR; Prinsen MBW; de Wit J; Sterrenburg JG; van Cauter F; den Ouden JE; van Altena AM; Massuger LF; Uitdehaag JCM; Buijsman RC; Zaman GJR
Front Immunol; 2020; 11():609490. PubMed ID: 33584686
[TBL] [Abstract][Full Text] [Related]
3. Identification of a 2-propanol analogue modulating the non-enzymatic function of indoleamine 2,3-dioxygenase 1.
Albini E; Coletti A; Greco F; Pallotta MT; Mondanelli G; Gargaro M; Belladonna ML; Volpi C; Bianchi R; Grohmann U; Macchiarulo A; Orabona C
Biochem Pharmacol; 2018 Dec; 158():286-297. PubMed ID: 30391205
[TBL] [Abstract][Full Text] [Related]
4. Distinct roles of immunoreceptor tyrosine-based motifs in immunosuppressive indoleamine 2,3-dioxygenase 1.
Albini E; Rosini V; Gargaro M; Mondanelli G; Belladonna ML; Pallotta MT; Volpi C; Fallarino F; Macchiarulo A; Antognelli C; Bianchi R; Vacca C; Puccetti P; Grohmann U; Orabona C
J Cell Mol Med; 2017 Jan; 21(1):165-176. PubMed ID: 27696702
[TBL] [Abstract][Full Text] [Related]
5. Interferon-γ induces a tryptophan-selective amino acid transporter in human colonic epithelial cells and mouse dendritic cells.
Bhutia YD; Babu E; Ganapathy V
Biochim Biophys Acta; 2015 Feb; 1848(2):453-62. PubMed ID: 25450809
[TBL] [Abstract][Full Text] [Related]
6. Galectin 3 protects from cisplatin-induced acute kidney injury by promoting TLR-2-dependent activation of IDO1/Kynurenine pathway in renal DCs.
Volarevic V; Markovic BS; Jankovic MG; Djokovic B; Jovicic N; Harrell CR; Fellabaum C; Djonov V; Arsenijevic N; Lukic ML
Theranostics; 2019; 9(20):5976-6001. PubMed ID: 31534532
[TBL] [Abstract][Full Text] [Related]
7. Forced IDO1 expression in dendritic cells restores immunoregulatory signalling in autoimmune diabetes.
Pallotta MT; Orabona C; Bianchi R; Vacca C; Fallarino F; Belladonna ML; Volpi C; Mondanelli G; Gargaro M; Allegrucci M; Talesa VN; Puccetti P; Grohmann U
J Cell Mol Med; 2014 Oct; 18(10):2082-91. PubMed ID: 25215657
[TBL] [Abstract][Full Text] [Related]
8. Indoleamine 2,3-Dioxygenase 1: A Promising Therapeutic Target in Malignant Tumor.
Song X; Si Q; Qi R; Liu W; Li M; Guo M; Wei L; Yao Z
Front Immunol; 2021; 12():800630. PubMed ID: 35003126
[TBL] [Abstract][Full Text] [Related]
9. Epacadostat stabilizes the apo-form of IDO1 and signals a pro-tumorigenic pathway in human ovarian cancer cells.
Rossini S; Ambrosino S; Volpi C; Belladonna ML; Pallotta MT; Panfili E; Suvieri C; Macchiarulo A; Mondanelli G; Orabona C
Front Immunol; 2024; 15():1346686. PubMed ID: 38333210
[TBL] [Abstract][Full Text] [Related]
10. Interactions of Indoleamine 2,3-dioxygenase-expressing LAMP3
Qu X; Wang Y; Jiang Q; Ren T; Guo C; Hua K; Qiu J
Cancer Commun (Lond); 2023 Nov; 43(11):1207-1228. PubMed ID: 37794698
[TBL] [Abstract][Full Text] [Related]
11. Tobacco carcinogen induces tryptophan metabolism and immune suppression via induction of indoleamine 2,3-dioxygenase 1.
Liang F; Wang GZ; Wang Y; Yang YN; Wen ZS; Chen DN; Fang WF; Zhang B; Yang L; Zhang C; Han SC; Yang FY; Wang D; Liang LJ; Wang Z; Zhao Y; Wang CL; Zhang L; Zhou GB
Signal Transduct Target Ther; 2022 Sep; 7(1):311. PubMed ID: 36068203
[TBL] [Abstract][Full Text] [Related]
12. Non-tumor cell IDO1 predominantly contributes to enzyme activity and response to CTLA-4/PD-L1 inhibition in mouse glioblastoma.
Zhai L; Ladomersky E; Dostal CR; Lauing KL; Swoap K; Billingham LK; Gritsina G; Wu M; McCusker RH; Binder DC; Wainwright DA
Brain Behav Immun; 2017 May; 62():24-29. PubMed ID: 28179106
[TBL] [Abstract][Full Text] [Related]
13. Targeting the IDO1 pathway in cancer: from bench to bedside.
Liu M; Wang X; Wang L; Ma X; Gong Z; Zhang S; Li Y
J Hematol Oncol; 2018 Aug; 11(1):100. PubMed ID: 30068361
[TBL] [Abstract][Full Text] [Related]
14. The expanding roles of 1-methyl-tryptophan (1-MT): in addition to inhibiting kynurenine production, 1-MT activates the synthesis of melatonin in skin cells.
Moreno AC; Clara RO; Coimbra JB; Júlio AR; Albuquerque RC; Oliveira EM; Maria-Engler SS; Campa A
FEBS J; 2013 Oct; 280(19):4782-92. PubMed ID: 23879623
[TBL] [Abstract][Full Text] [Related]
15. Tryptophan metabolism activation by indoleamine 2,3-dioxygenase in adipose tissue of obese women: an attempt to maintain immune homeostasis and vascular tone.
Wolowczuk I; Hennart B; Leloire A; Bessede A; Soichot M; Taront S; Caiazzo R; Raverdy V; Pigeyre M; ; Guillemin GJ; Allorge D; Pattou F; Froguel P; Poulain-Godefroy O
Am J Physiol Regul Integr Comp Physiol; 2012 Jul; 303(2):R135-43. PubMed ID: 22592557
[TBL] [Abstract][Full Text] [Related]
16. IDO1 metabolites activate β-catenin signaling to promote cancer cell proliferation and colon tumorigenesis in mice.
Thaker AI; Rao MS; Bishnupuri KS; Kerr TA; Foster L; Marinshaw JM; Newberry RD; Stenson WF; Ciorba MA
Gastroenterology; 2013 Aug; 145(2):416-25.e1-4. PubMed ID: 23669411
[TBL] [Abstract][Full Text] [Related]
17. Tumor endothelial cell up-regulation of IDO1 is an immunosuppressive feed-back mechanism that reduces the response to CD40-stimulating immunotherapy.
Georganaki M; Ramachandran M; Tuit S; Núñez NG; Karampatzakis A; Fotaki G; van Hooren L; Huang H; Lugano R; Ulas T; Kaunisto A; Holland EC; Ellmark P; Mangsbo SM; Schultze J; Essand M; Tugues S; Dimberg A
Oncoimmunology; 2020; 9(1):1730538. PubMed ID: 32231867
[TBL] [Abstract][Full Text] [Related]
18. Indoleamine 2,3-dioxygenase-expressing leukemic dendritic cells impair a leukemia-specific immune response by inducing potent T regulatory cells.
Curti A; Trabanelli S; Onofri C; Aluigi M; Salvestrini V; Ocadlikova D; Evangelisti C; Rutella S; De Cristofaro R; Ottaviani E; Baccarani M; Lemoli RM
Haematologica; 2010 Dec; 95(12):2022-30. PubMed ID: 20801903
[TBL] [Abstract][Full Text] [Related]
19. Indoleamine 2,3-dioxygenase 1 (IDO1): an up-to-date overview of an eclectic immunoregulatory enzyme.
Pallotta MT; Rossini S; Suvieri C; Coletti A; Orabona C; Macchiarulo A; Volpi C; Grohmann U
FEBS J; 2022 Oct; 289(20):6099-6118. PubMed ID: 34145969
[TBL] [Abstract][Full Text] [Related]
20. Tryptophan: A Rheostat of Cancer Immune Escape Mediated by Immunosuppressive Enzymes IDO1 and TDO.
Kim M; Tomek P
Front Immunol; 2021; 12():636081. PubMed ID: 33708223
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
